8-K: ALT5 Sigma Acquires Mswipe, Reports Record Q1 Fintech Revenue and Strategic Expansion

ALT5 Sigma Corporation announced the acquisition of Mswipe, a multi-currency payment card service, alongside reporting record first-quarter 2025 fintech revenues and positive strategic outlook.

Summary

• ALT5 Sigma Corporation acquired Mswipe, a provider of multi-currency, fiatand crypto-enabled payment card services, effective May 9, 2025.
• The acquisition consideration included 1 million restricted shares of ALT5 common stock valued at $6.10 per share, 500,000 four-year common stock warrants with a $5.50 exercise price, shares in Alyea Therapeutics Corporation valued at $4.8 million, and two 14-month promissory notes totaling approximately $1 million at 3.99% interest.
• An existing 14-month promissory note at Mswipe for approximately $5.1 million was also acknowledged, with its interest rate reset to 3.99%.
• An earn-out payment of $20 million (cash or unregistered shares) is contingent on Mswipe's operating subsidiaries generating a minimum of $15 million in annualized or actual total revenue from assets owned as of May 9, 2025.
• For the fiscal first quarter ended March 29, 2025, ALT5's Fintech revenues reached a record $5.51 million, marking the third consecutive record quarter for the segment.
• The company reported a gross profit of $2.59 million, representing a 47% gross margin.
• Adjusted EBITDA for the Fintech segment was $1.15 million, while the Biotech segment had an Adjusted EBITDA of $(58) thousand, and Corporate and other was $(1.26) million, resulting in a total Adjusted EBITDA of $(168) thousand.
• Cash and cash equivalents stood at $10.8 million as of March 29, 2025.
• Mswipe's audited financial statements for the year ended April 30, 2025, show sales of $2.81 million (down from $3.15 million in 2024) but net earnings of $523,049 (up from $136,711 in 2024).
• Mswipe's cash decreased from $402,935 in 2024 to $99,610 in 2025, and net cash provided for operating activities shifted from a positive $591,815 in 2024 to a negative $(354,210) in 2025.
• Pro forma combined financial statements for ALT5 Sigma and Mswipe indicate that as of March 29, 2025, total assets would be approximately $98.0 million, liabilities $60.9 million, and shareholders' equity $33.3 million.
• Pro forma net loss for the year ended December 28, 2024, would have been approximately $7.1 million, increasing basic loss per share by $0.08 to $0.64.
• Pro forma net loss for the three months ended March 29, 2025, would have been approximately $2.9 million, increasing basic loss per share by $0.01 to $0.19.

Sentiment

Score: 8

Explanation: The sentiment is highly positive due to the strategic acquisition of Mswipe, which is expected to be immediately accretive to revenue and EBITDA, and the achievement of record Q1 2025 Fintech revenues. The company's focus on bridging crypto and traditional finance, coupled with anticipated regulatory tailwinds, suggests strong future growth potential, despite some historical financial declines in the acquired entity and pro forma net losses.

Positives

• Achieved record Fintech revenues of $5.51 million for Q1 2025, marking the third consecutive record quarter for the segment.
• The Mswipe acquisition is strategically significant, bridging the crypto economy and traditional financial systems with existing integration into ALT5 Pay.
• Management expects the Mswipe acquisition to be immediately accretive to both revenue and EBITDA upon close.
• Mswipe's net earnings significantly increased to $523,049 in 2025 from $136,711 in 2024, despite a decline in sales.
• Mswipe demonstrated improved gross profit and a significant reduction in administrative expenses, leading to higher operating earnings and net earnings.
• ALT5 Sigma's annualized revenue run rate is now north of $22 million based on Q1 2025 performance.
• The company anticipates favorable regulatory tailwinds throughout fiscal 2025 and beyond, driving additional growth opportunities.

Negatives

• Mswipe's historical sales declined from $3.15 million in 2024 to $2.81 million in 2025.
• Mswipe's cash and cash equivalents significantly decreased from $402,935 in 2024 to $99,610 in 2025.
• Mswipe's net cash provided for operating activities shifted from a positive $591,815 in 2024 to a negative $(354,210) in 2025.
• The pro forma combined financial statements indicate an increase in net loss and basic loss per share for the combined entity post-acquisition, despite the expected revenue and EBITDA accretion.
• Total Adjusted EBITDA for ALT5 Sigma was negative $(168) thousand for Q1 2025, primarily due to corporate and biotech segment losses.

Risks

• Exposure to international currency risks.
• Potential third-party or customer credit risks.
• Risk of liability claims stemming from ALT5's services.
• Technology challenges for future growth or expansion.
• Uncertainty regarding the efficacy of biotech products (JAN 101 for PAD, JAN 123 for CRPS).
• Uncertainty regarding the timing of commencement of clinical trials for biotech products.
• Uncertainty regarding FDA approval pathways for biotech products, specifically the 505(b)(2) pathway for JAN 123.
• Uncertainty regarding the immediate market disruption potential of JAN 101 upon approval.

Future Outlook

Management expects the Mswipe acquisition to be immediately accretive to both revenue and EBITDA upon close. The company anticipates continued increased demand in the first half of Q2 2025 and favorable regulatory tailwinds throughout fiscal 2025 and beyond, which are expected to drive additional growth opportunities. The company is also in the process of separating its biotech business, Alyea Therapeutics Corporation, which is developing a patented product (JAN123) for Complex Regional Pain Syndrome (CRPS) with Orphan Drug Designation from the FDA.

Management Comments

• "We are thrilled to announce the acquisition of Mswipe and welcome their talented team to the ALT5 family."
• "The integration between ALT5 and Mswipe technologies is already complete and live with multiple customers."
• "Enabling instant conversion of stablecoin or other cryptocurrency balances into fiat and allowing customers to pay merchants in their local currency is a powerful capability that significantly expands real-world use cases for digital assets."
• "Our customers are demanding these solutions as they navigate the evolving DeFi landscape and we continue to evolve our capabilities to meet and exceed these needs."
• "We are also pleased that Q1, 2025 met our expectations with another record quarter under our belt that now pushes our annualized run rate to north of $22m."
• "We continue to see increased demand in the first half of Q2 and are seeing favorable tailwinds from a regulatory perspective continuing throughout fiscal 2025 and beyond driving additional opportunities for growth."

Industry Context

The acquisition of Mswipe positions ALT5 Sigma to bridge the gap between the crypto economy and traditional financial systems, a critical trend in the evolving DeFi landscape. By offering multi-currency, fiatand crypto-enabled payment card services, the company is addressing the growing demand for seamless conversion and spending of digital assets in real-world scenarios. The emphasis on robust compliance frameworks and regulatory alignment aligns with the increasing scrutiny and development of regulations within the digital asset space, suggesting a proactive approach to industry challenges and opportunities.

Comparison to Industry Standards

• The filing highlights the strategic fit and existing integration of Mswipe's platform with ALT5 Pay, which is crucial for competitive advantage in the rapidly evolving crypto-fiat payment sector.
• While specific comparable companies or projects are not detailed, the acquisition's focus on robust compliance and real-time exchange capabilities positions ALT5 Sigma to compete effectively in the global digital payments market, where interoperability and regulatory adherence are becoming industry benchmarks.
• The ability to enable instant conversion of stablecoin or other cryptocurrency balances into fiat for merchant payments is a key capability that aligns with the broader industry trend of increasing real-world utility for digital assets, a feature sought after by institutional partners and end-users.

Related Party Transactions

• Mswipe's balance sheet includes 'Advances to a Company Under Common Control' of $160,314 as of April 30, 2025, and $235,144 as of April 30, 2024.
• Mswipe's balance sheet includes 'Advance to Director' of $248,558 as of April 30, 2025, and $3,872 as of April 30, 2024.

Stakeholder Impact

• Shareholders: Potential for value creation through strategic acquisition and revenue growth, but also potential dilution from share and warrant issuance.
• Employees: Mswipe's team is welcomed into the ALT5 family, indicating integration and potential new opportunities.
• Customers: Expanded services with multi-currency, fiatand crypto-enabled payment card services, enhancing user experience and real-world utility for digital assets.
• Creditors: Issuance of new promissory notes and acknowledgment of existing debt at Mswipe level impacts the company's debt profile.

Next Steps

• Integration of Mswipe's operations and technology with ALT5's existing solutions.
• Making the combined card issuer offering immediately available to ALT5's existing 1000+ customers.
• Continued focus on meeting increased demand in the first half of Q2 2025.
• Separation of the biotech business into Alyea Therapeutics Corporation.
• Further development and potential clinical trials for biotech products like JAN123 for CRPS.

Key Dates

Recommendation

The acquisition of Mswipe is a highly strategic move that significantly expands ALT5 Sigma's capabilities in the rapidly growing digital payments and crypto-fiat bridging space. The immediate accretion to revenue and EBITDA, coupled with ALT5's consistent record-breaking fintech revenue performance and positive outlook on regulatory tailwinds, positions the company for substantial growth. While the pro forma net loss increases, this is common with growth-oriented acquisitions and is offset by the strategic value and expected operational synergies. The company is actively addressing market demand and expanding its core offerings, making it an attractive investment for long-term growth in the fintech sector.

Keywords

Fintech, Blockchain, Digital Assets, Cryptocurrency, Payment Gateway, Mswipe, Acquisition, SEC Filing, Financial Results, Earnings, EBITDA, Tokenization, Trading, Clearing, Settlement, Biotech, Alyea Therapeutics, CRPS, Orphan Drug Designation